0001085037-23-000101.txt : 20230829 0001085037-23-000101.hdr.sgml : 20230829 20230829140848 ACCESSION NUMBER: 0001085037-23-000101 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230829 DATE AS OF CHANGE: 20230829 EFFECTIVENESS DATE: 20230829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ME THERAPEUTICS HOLDINGS INC. CENTRAL INDEX KEY: 0001990555 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490912 FILM NUMBER: 231220926 BUSINESS ADDRESS: STREET 1: 177 ROBSON STREET CITY: VANCOUVER STATE: A1 ZIP: V6B 0N3 BUSINESS PHONE: 2365167714 MAIL ADDRESS: STREET 1: 177 ROBSON STREET CITY: VANCOUVER STATE: A1 ZIP: V6B 0N3 D 1 primary_doc.xml X0708 D LIVE 0001990555 ME THERAPEUTICS HOLDINGS INC. 177 ROBSON STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6B 0N3 2365167714 BRITISH COLUMBIA, CANADA None None Corporation true 2021 Salim Dhanji 177 Robson Street Vancouver A1 BRITISH COLUMBIA, CANADA V6B 0N3 Executive Officer Director Chief Executive Officer Kenneth Harder 177 Robson Street Vancouver A1 BRITISH COLUMBIA, CANADA V6B 0N3 Director John Priatel 177 Robson Street Vancouver A1 BRITISH COLUMBIA, CANADA V6B 0N3 Director Karim Nanji 177 Robson Street Vancouver A1 BRITISH COLUMBIA, CANADA V6B 0N3 Director Quinn Martin 177 Robson Street Vancouver A1 BRITISH COLUMBIA, CANADA V6B 0N3 Executive Officer Chief Financial Officer Jamil Kassam 177 Robson Street Vancouver A1 BRITISH COLUMBIA, CANADA V6B 0N3 Executive Officer Corporate Secretary Biotechnology Decline to Disclose 06b false 2023-08-09 false true false 0 3350 3350 0 CDN$4,500 based on Bank of Canada exchange rate of $0.7445 on August 9, 2023. false 2 0 0 0 false ME THERAPEUTICS HOLDINGS INC. /s/ Salim Dhanji Salim Dhanji Chief Executive Officer 2023-08-29